These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2359396)
1. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease]. Takami H; Shikata J; Ozaki O; Mimura T; Ito K Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396 [TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma. Takami H; Ito K Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide in patients with endocrine tumors. Takami H; Shikata J; Kakudo K; Ito K J Surg Oncol; 1990 Jan; 43(1):28-32. PubMed ID: 2296192 [TBL] [Abstract][Full Text] [Related]
4. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors. Carter WB; Taylor RL; Kao PC; Heath H J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803 [TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay for calcitonin gene-related peptide and its measurement in sera of patients with thyroid disease. Yoshida H; Hamada N; Noh J; Ito K; Morii H Endocrinol Jpn; 1992 Feb; 39(1):81-91. PubMed ID: 1376685 [TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects]. Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074 [TBL] [Abstract][Full Text] [Related]
7. Elevated plasma calcitonin gene-related peptide and the symptoms associated with medullary thyroid cancer. Rubinstein C; Fletcher DR; Shulkes A; Hardy KJ Aust N Z J Surg; 1992 Nov; 62(11):892-6. PubMed ID: 20169709 [TBL] [Abstract][Full Text] [Related]
8. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706 [TBL] [Abstract][Full Text] [Related]
9. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor]. Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708 [TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening. Schifter S Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082 [TBL] [Abstract][Full Text] [Related]
11. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma. Wimalawansa SJ J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796 [TBL] [Abstract][Full Text] [Related]
12. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin. Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061 [TBL] [Abstract][Full Text] [Related]
13. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma. Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561 [TBL] [Abstract][Full Text] [Related]
17. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100 [TBL] [Abstract][Full Text] [Related]
18. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126 [TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer. Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524 [TBL] [Abstract][Full Text] [Related]